Cargando…

Novel lipid antigens for NKT cells in cancer

Cancer immunotherapy aims to unleash the power of the immune system against tumors without the side effects of traditional chemotherapy. Immunotherapeutic methods vary widely, but all follow the same basic principle: overcome the barriers utilized by cancers to avoid immune destruction. These approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Michael S., Webb, Tonya J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613688/ https://www.ncbi.nlm.nih.gov/pubmed/37908366 http://dx.doi.org/10.3389/fimmu.2023.1173375

Ejemplares similares

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

iNKT Cells and Their Potential Lipid Ligands during Viral Infection
por: Opasawatchai, Anunya, et al.
Publicado: (2015)

Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor
por: Humeniuk, Piotr, et al.
Publicado: (2019)

How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets
por: Wang, Haiguang, et al.
Publicado: (2018)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Publisher Correction: Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor
por: Humeniuk, Piotr, et al.
Publicado: (2019)

Thymic resident NKT cell subsets show differential requirements for CD28 co-stimulation during antigenic activation
por: Shissler, Susannah C., et al.
Publicado: (2020)

Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
por: Tiwary, Shweta, et al.
Publicado: (2019)

Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
por: Jimeno, Rebeca, et al.
Publicado: (2019)

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
por: East, James E., et al.
Publicado: (2012)

Correction: Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
por: Jimeno, Rebeca, et al.
Publicado: (2020)

NKT Cell Networks in the Regulation of Tumor Immunity
por: Robertson, Faith C., et al.
Publicado: (2014)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Regulation of NKT Cell Localization in Homeostasis and Infection
por: Slauenwhite, Drew, et al.
Publicado: (2015)

Dynamics of NKT-Cell Responses to Chlamydial Infection
por: Shekhar, Sudhanshu, et al.
Publicado: (2015)

iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)

The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018)

Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer
por: Marrero, Idania, et al.
Publicado: (2015)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

NKT Cell Responses to B Cell Lymphoma
por: Li, Junxin, et al.
Publicado: (2014)

Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018)

Unique Interplay between Sugar and Lipid in Determining the Antigenic Potency of Bacterial Antigens for NKT Cells
por: Girardi, Enrico, et al.
Publicado: (2011)

CD8(+) T-cell immunity orchestrated by iNKT cells
por: Qin, Yingyu, et al.
Publicado: (2023)

The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions
por: Macho-Fernandez, Elodie, et al.
Publicado: (2015)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
por: Shissler, Susannah C., et al.
Publicado: (2017)

Type II NKT Cells: An Elusive Population With Immunoregulatory Properties
por: Singh, Avadhesh Kumar, et al.
Publicado: (2018)

The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells
por: Gerth, Evelyn, et al.
Publicado: (2019)

New insights into iNKT cells and their roles in liver diseases
por: Gu, Xinyu, et al.
Publicado: (2022)

Invariant NKT cells are more abundant in peanut-allergic adults and a subset of CD8(+) iNKT cells are depleted after peanut oil exposure
por: Hopkins, Georgina V., et al.
Publicado: (2023)

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells
por: Fujii, Shin-ichiro, et al.
Publicado: (2017)

The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
por: Won, Hee Yeun, et al.
Publicado: (2021)

Imaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial Immunity
por: Delovitch, Terry L.
Publicado: (2015)

The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues
por: Cortesi, Filippo, et al.
Publicado: (2018)

PLZF Controls the Expression of a Limited Number of Genes Essential for NKT Cell Function
por: Gleimer, Michael, et al.
Publicado: (2012)

CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections
por: Chung, Brian K., et al.
Publicado: (2015)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019)

ER stress in antigen‐presenting cells promotes NKT cell activation through endogenous neutral lipids
por: Govindarajan, Srinath, et al.
Publicado: (2020)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5r3i0hr3qsnteft49se26eu4a5